| |
| |
|
| |
|
|
|
| |
Content for site developed under the guidance of the TRACK Advisory Council.
|
|
 |
|
| |
 |
|
|
|
| |
_Prevention of Venous Thromboembolism Following Surgery: Choosing an Optimal Strategy |
| |
|
| |
|
|
This CME activity has expired. CME credit is no longer available for this activity. However, the content will remain posted for your viewing convenience. |
HARDWARE AND SOFTWARE SPECIFICATIONS NEEDED TO VIEW SITE
The programs requires version 5.5 browsers or higher from Microsoft or Netscape or Firefox 1.0. Certain activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Macromedia Flash, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.
|
ACCREDITATION STATEMENT |
|
The Elsevier Office of Continuing Medical Education (EOCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the ACCME by the EOCME. This activity is jointly sponsored by the EOCME and Excerpta Medica. |
|
FACULTY DISCLOSURES |
|
As a sponsor accredited by the ACCME, it is the policy of the EOCME to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member has with the manufacturer(s) of any commercial product discussed during his/her presentation. The faculty of this CME activity disclose the following:
| Faculty Member |
|
Manufacturer |
|
Relationship |
| Deepak L. Bhatt, MD |
|
Bristol-Myers Squibb Company, The sanofi-aventis Group Bacchus Vascular, Inc. Bayer Pharmaceuticals Corporation |
|
Grants/Research Support Consultant Grants/Research Support |
| Geno J. Merli, MD |
|
AstraZeneca, The sanofi-aventis Group |
|
Grants/Research Support, Consultant, Speaker’s Bureau |
| Geno J. Merli, MD |
|
Bacchus Vascular, Inc. |
|
Consultant |
| Geno J. Merli, MD |
|
Bayer Pharmaceuticals Corporation |
|
Grants/Research Support | |
|
INFORMATION ON CME CREDIT |
|
The EOCME designates this educational activity for a maximum of 1 category 1 credit toward the American Medical Association (AMA) Physician’s Recognition Award (PRA). Each physician should claim only those hours of credit that he/she actually spent in the educational activity. |
|
FINANCIAL SUPPORT
|
|
This CME activity is jointly sponsored by the EOCME and Excerpta Medica and supported by an unrestricted educational grant from sanofi-aventis U.S. |
|
INTENDED AUDIENCE |
|
This activity is intended for orthopedic and general surgeons. |
|
GOAL OF THE ACTIVITY |
|
This activity will educate participants on the risk of VTE among patients that undergo surgical procedures, the surgical procedures that are at highest risk of VTE, and how surgical patients can be protected against VTE. The participants will be able to describe which surgical patients should be prophylaxed to prevent VTE and which forms of anticoagulation should be used.
|
EDUCATIONAL OBJECTIVES |
|
Upon completion of this activity, participants will be able to
- Recognize and list which surgical procedures place patients at risk for VTE
- Determine whether a patient that undergoes a surgical procedure needs thromboprophylaxis
- Utilize thromboprophylaxis appropriately, which may lead to a decrease in preventable death in surgical patients
This activity may contain references to off-label/unapproved uses of drugs or medical devices. Please consult the product prescribing information for full disclosure of labeled uses.
|
CONTENT DEVELOPMENT COMMITTEE |
|
Deepak L. Bhatt, MD
Mark J. Flanick, MS
Geno J. Merli, MD | |
|
CME PARTICIPANT DEMOGRAPHICS |
|
Prevention of venous thromboembolism following surgery: Choosing an optimal strategy
Release date: March 18, 2005
Expiration date: March 18, 2007
Estimated time to complete activity: 1 hour
| | |
The following slide presentation discusses the risk of venous thromboembolism (VTE) among patients undergoing surgical procedures, the surgical procedures that are associated with increased risk of VTE, and how surgical patients can be protected against VTE. After viewing the presentation, the participants will be able to describe which surgical patients should be prophylaxed to prevent VTE and which forms of anticoagulation should be used.
 View this lecture
|
|
| |
|
|
| |
|
|